NL-OMON29093招募中不适用
‘Tobramycin nebulisation with I-neb (TONI) study in children with cystic fibrosis: pharmacokinetics and safety’.
H.M. Janssens, pulmonologist at Erasmus Medical Center, Rotterdam, The Netherlands0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Clinical diagnosis of CF and a positive sweat test or two CF-related mutations;
- •Either: early PA infection or colonization with PA requiring eradication with inhaled tobramycin, or: chronic PA colonization requiring maintenance therapy with inhaled tobramycin;
排除标准
- •Severe acute exacerbation of pulmonary infection (needing intravenous treatment);
研究者
相似试验
已完成
不适用
Tobramycin nebulisation with I-neb (TONI) study in children with cystic fibrosis: pharmacokinetics and safety'Cystic Fibrosis' en 'CF'100836241000401810024970NL-OMON39647Erasmus MC, Universitair Medisch Centrum Rotterdam24
进行中（未招募）
不适用
Tobramycin nebulisation with I-neb (TONI) study in children with cystic fibrosis: pharmacokinetics and safetyMedDRA version: 14.1Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersCystic fibrosisEUCTR2012-002503-17-NLErasmus University Medical Centre
已完成
3 期
ong-term inhaled nebulized tobramycin in patients with non-cystic fibrosis bronchiectasis. A randomized placebo controlled trial. The BATTLE study Bronchiectasis And Tobramycin SoluTion InhaLation ThErapy.bronchiectasis10006436NL-OMON47248Medisch Centrum Alkmaar58
已完成
2 期
Inhaled Nebulized Tobramycin in Non-cystic Fibrosis BronchiectasisNon-CF BronchiectasisNCT02657473Medical Center Alkmaar58
尚未招募
不适用
Inhalation of tobramycin for the patients with persistent respiratory infection by Psudomonas aeruginosaPersistent respiratory infection by Pseudomonas aeruginosaJPRN-UMIN000002893Kumamoto university hospital5